- Home
- LNTH vs INGR Comparison
LNTH vs INGR Comparison
Compare LNTH & INGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LNTH | INGR |
|---|---|---|
| Founded | 1956 | 1906 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 7.1B |
| IPO Year | 2015 | 1997 |
Fundamental Metrics
Financial Performance| Metric | LNTH | INGR |
|---|---|---|
| Price | $68.61 | $110.80 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 7 |
| Target Price | $78.00 | ★ $134.57 |
| AVG Volume (30 Days) | ★ 1.2M | 819.3K |
| Earning Date | 11-06-2025 | 02-03-2026 |
| Dividend Yield | N/A | ★ 2.97% |
| EPS Growth | N/A | ★ N/A |
| EPS | 2.39 | ★ 10.01 |
| Revenue | $1,525,933,000.00 | ★ $7,262,000,000.00 |
| Revenue This Year | $0.01 | N/A |
| Revenue Next Year | $1.24 | $1.23 |
| P/E Ratio | $27.55 | ★ $11.04 |
| Revenue Growth | ★ 1.95 | N/A |
| 52 Week Low | $47.25 | $102.31 |
| 52 Week High | $111.29 | $141.78 |
Technical Indicators
Market Signals| Indicator | LNTH | INGR |
|---|---|---|
| Relative Strength Index (RSI) | 72.42 | 52.13 |
| Support Level | $64.13 | $105.83 |
| Resistance Level | $67.01 | $113.90 |
| Average True Range (ATR) | 2.27 | 1.76 |
| MACD | 0.42 | 0.53 |
| Stochastic Oscillator | 97.77 | 61.59 |
Price Performance
Historical ComparisonAbout LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About INGR Ingredion Incorporated
Ingredion is an ingredients provider for the food, beverage, brewing, and animal nutrition industries. The company processes corn, tapioca, potatoes, stevia, grains, fruits, gums, and vegetables into value-added ingredients. The company sells specialty ingredients that include starch-based texturizers and natural alternative sweeteners such as stevia. Ingredion also sells commodity ingredients that include sweeteners, such as high-fructose corn syrup, and starches, such as those used for sustainable packaging, as well as plant-based proteins.